Routine screening of antibiotic-resistant bacteria in acute rehabilitation units

The objective of this study was to evaluate the epidemiology of antibiotic-resistant bacteria among motor impaired patients admitted to an acute rehabilitation unit. From January 2000 to December 2002, the acute rehabilitation units of R. Poincare Hospital have screened patients for methicillin-resi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pathologie biologie (Paris) 2004-12, Vol.52 (10), p.602-606
Hauptverfasser:	Lawrence, C, Ohana, S, Ronco, E, Dizien, O, Denys, P, Laffont, I, Lortat-Jacob, S, Vezant, P, Doussin, F, Gaillard, J L
Format:	Artikel
Sprache:	fre
Schlagworte:	Drug Resistance, Bacterial Enterobacteriaceae - drug effects Humans Methicillin Resistance Rehabilitation Staphylococcus aureus - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	606
container_issue	10
container_start_page	602
container_title	Pathologie biologie (Paris)
container_volume	52
creator	Lawrence, C Ohana, S Ronco, E Dizien, O Denys, P Laffont, I Lortat-Jacob, S Vezant, P Doussin, F Gaillard, J L
description	The objective of this study was to evaluate the epidemiology of antibiotic-resistant bacteria among motor impaired patients admitted to an acute rehabilitation unit. From January 2000 to December 2002, the acute rehabilitation units of R. Poincare Hospital have screened patients for methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase enterobacteria (ESBL-EB) carriage by nasal and rectal swab at admission, every month and exit. Finally, MRSA was isolated form screening or diagnosis samples of 360 patients and ESBL-EB from screening or diagnosis samples of 170 patients, corresponding respectively to an incidence of 3.6 for 1000 days of hospitalization (DH) and 1.7 for 1000 DH. 66% (236/360) of MRSA carriers and 58% of ESBL-EB carriers were identified only by screening samples. Carriage origin was identified for year 2002: Cases were imported for 40% (26/65) of MRSA carriers and 43% (18/42) of ESBL-EB carriers. The median acquisition delays were of 31 days [3-154] for MRSA and 19 days [3-317] for ESBL-EB. This allowed to set up contact precautions for more than 2 fold patients that would have allowed diagnosis samples alone.
doi_str_mv	10.1016/j.patbio.2004.09.002
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67171452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67171452</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-65ab9c9f3b42fa6de07c9f03bf1e64f502a040c10273d22d0186f68b9a7171a23</originalsourceid><addsrcrecordid>eNo1kE1LxDAYhHNQ3HX1H4jk5K31zUfT7VEWv2BBET2XN2miWbppTdKD_94urqdhhoeBGUKuGJQMmLrdlSNm7YeSA8gSmhKAn5AlCNUUa8bkgpyntANgNZPsjCxYVTVKMFiS17dhyj5Ymky0NvjwSQdHMWQ_12VvimiTT3kOqEaTbfRIfaBopmxptF-ofe8zZj8EOgWf0wU5ddgne3nUFfl4uH_fPBXbl8fnzd22GJlocqEq1I1pnNCSO1SdhXp2ILRjVklXAUeQYBjwWnScd8DWyqm1brCeRyAXK3Lz1zvG4XuyKbd7n4ztewx2mFKrDpysDuD1EZz03nbtGP0e40_7_4H4BQ1jXww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67171452</pqid></control><display><type>article</type><title>Routine screening of antibiotic-resistant bacteria in acute rehabilitation units</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Lawrence, C ; Ohana, S ; Ronco, E ; Dizien, O ; Denys, P ; Laffont, I ; Lortat-Jacob, S ; Vezant, P ; Doussin, F ; Gaillard, J L</creator><creatorcontrib>Lawrence, C ; Ohana, S ; Ronco, E ; Dizien, O ; Denys, P ; Laffont, I ; Lortat-Jacob, S ; Vezant, P ; Doussin, F ; Gaillard, J L</creatorcontrib><description>The objective of this study was to evaluate the epidemiology of antibiotic-resistant bacteria among motor impaired patients admitted to an acute rehabilitation unit. From January 2000 to December 2002, the acute rehabilitation units of R. Poincare Hospital have screened patients for methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase enterobacteria (ESBL-EB) carriage by nasal and rectal swab at admission, every month and exit. Finally, MRSA was isolated form screening or diagnosis samples of 360 patients and ESBL-EB from screening or diagnosis samples of 170 patients, corresponding respectively to an incidence of 3.6 for 1000 days of hospitalization (DH) and 1.7 for 1000 DH. 66% (236/360) of MRSA carriers and 58% of ESBL-EB carriers were identified only by screening samples. Carriage origin was identified for year 2002: Cases were imported for 40% (26/65) of MRSA carriers and 43% (18/42) of ESBL-EB carriers. The median acquisition delays were of 31 days [3-154] for MRSA and 19 days [3-317] for ESBL-EB. This allowed to set up contact precautions for more than 2 fold patients that would have allowed diagnosis samples alone.</description><identifier>ISSN: 0369-8114</identifier><identifier>DOI: 10.1016/j.patbio.2004.09.002</identifier><identifier>PMID: 15596310</identifier><language>fre</language><publisher>France</publisher><subject>Drug Resistance, Bacterial ; Enterobacteriaceae - drug effects ; Humans ; Methicillin Resistance ; Rehabilitation ; Staphylococcus aureus - drug effects</subject><ispartof>Pathologie biologie (Paris), 2004-12, Vol.52 (10), p.602-606</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15596310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lawrence, C</creatorcontrib><creatorcontrib>Ohana, S</creatorcontrib><creatorcontrib>Ronco, E</creatorcontrib><creatorcontrib>Dizien, O</creatorcontrib><creatorcontrib>Denys, P</creatorcontrib><creatorcontrib>Laffont, I</creatorcontrib><creatorcontrib>Lortat-Jacob, S</creatorcontrib><creatorcontrib>Vezant, P</creatorcontrib><creatorcontrib>Doussin, F</creatorcontrib><creatorcontrib>Gaillard, J L</creatorcontrib><title>Routine screening of antibiotic-resistant bacteria in acute rehabilitation units</title><title>Pathologie biologie (Paris)</title><addtitle>Pathol Biol (Paris)</addtitle><description>The objective of this study was to evaluate the epidemiology of antibiotic-resistant bacteria among motor impaired patients admitted to an acute rehabilitation unit. From January 2000 to December 2002, the acute rehabilitation units of R. Poincare Hospital have screened patients for methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase enterobacteria (ESBL-EB) carriage by nasal and rectal swab at admission, every month and exit. Finally, MRSA was isolated form screening or diagnosis samples of 360 patients and ESBL-EB from screening or diagnosis samples of 170 patients, corresponding respectively to an incidence of 3.6 for 1000 days of hospitalization (DH) and 1.7 for 1000 DH. 66% (236/360) of MRSA carriers and 58% of ESBL-EB carriers were identified only by screening samples. Carriage origin was identified for year 2002: Cases were imported for 40% (26/65) of MRSA carriers and 43% (18/42) of ESBL-EB carriers. The median acquisition delays were of 31 days [3-154] for MRSA and 19 days [3-317] for ESBL-EB. This allowed to set up contact precautions for more than 2 fold patients that would have allowed diagnosis samples alone.</description><subject>Drug Resistance, Bacterial</subject><subject>Enterobacteriaceae - drug effects</subject><subject>Humans</subject><subject>Methicillin Resistance</subject><subject>Rehabilitation</subject><subject>Staphylococcus aureus - drug effects</subject><issn>0369-8114</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1LxDAYhHNQ3HX1H4jk5K31zUfT7VEWv2BBET2XN2miWbppTdKD_94urqdhhoeBGUKuGJQMmLrdlSNm7YeSA8gSmhKAn5AlCNUUa8bkgpyntANgNZPsjCxYVTVKMFiS17dhyj5Ymky0NvjwSQdHMWQ_12VvimiTT3kOqEaTbfRIfaBopmxptF-ofe8zZj8EOgWf0wU5ddgne3nUFfl4uH_fPBXbl8fnzd22GJlocqEq1I1pnNCSO1SdhXp2ILRjVklXAUeQYBjwWnScd8DWyqm1brCeRyAXK3Lz1zvG4XuyKbd7n4ztewx2mFKrDpysDuD1EZz03nbtGP0e40_7_4H4BQ1jXww</recordid><startdate>200412</startdate><enddate>200412</enddate><creator>Lawrence, C</creator><creator>Ohana, S</creator><creator>Ronco, E</creator><creator>Dizien, O</creator><creator>Denys, P</creator><creator>Laffont, I</creator><creator>Lortat-Jacob, S</creator><creator>Vezant, P</creator><creator>Doussin, F</creator><creator>Gaillard, J L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200412</creationdate><title>Routine screening of antibiotic-resistant bacteria in acute rehabilitation units</title><author>Lawrence, C ; Ohana, S ; Ronco, E ; Dizien, O ; Denys, P ; Laffont, I ; Lortat-Jacob, S ; Vezant, P ; Doussin, F ; Gaillard, J L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-65ab9c9f3b42fa6de07c9f03bf1e64f502a040c10273d22d0186f68b9a7171a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2004</creationdate><topic>Drug Resistance, Bacterial</topic><topic>Enterobacteriaceae - drug effects</topic><topic>Humans</topic><topic>Methicillin Resistance</topic><topic>Rehabilitation</topic><topic>Staphylococcus aureus - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lawrence, C</creatorcontrib><creatorcontrib>Ohana, S</creatorcontrib><creatorcontrib>Ronco, E</creatorcontrib><creatorcontrib>Dizien, O</creatorcontrib><creatorcontrib>Denys, P</creatorcontrib><creatorcontrib>Laffont, I</creatorcontrib><creatorcontrib>Lortat-Jacob, S</creatorcontrib><creatorcontrib>Vezant, P</creatorcontrib><creatorcontrib>Doussin, F</creatorcontrib><creatorcontrib>Gaillard, J L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pathologie biologie (Paris)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lawrence, C</au><au>Ohana, S</au><au>Ronco, E</au><au>Dizien, O</au><au>Denys, P</au><au>Laffont, I</au><au>Lortat-Jacob, S</au><au>Vezant, P</au><au>Doussin, F</au><au>Gaillard, J L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Routine screening of antibiotic-resistant bacteria in acute rehabilitation units</atitle><jtitle>Pathologie biologie (Paris)</jtitle><addtitle>Pathol Biol (Paris)</addtitle><date>2004-12</date><risdate>2004</risdate><volume>52</volume><issue>10</issue><spage>602</spage><epage>606</epage><pages>602-606</pages><issn>0369-8114</issn><abstract>The objective of this study was to evaluate the epidemiology of antibiotic-resistant bacteria among motor impaired patients admitted to an acute rehabilitation unit. From January 2000 to December 2002, the acute rehabilitation units of R. Poincare Hospital have screened patients for methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase enterobacteria (ESBL-EB) carriage by nasal and rectal swab at admission, every month and exit. Finally, MRSA was isolated form screening or diagnosis samples of 360 patients and ESBL-EB from screening or diagnosis samples of 170 patients, corresponding respectively to an incidence of 3.6 for 1000 days of hospitalization (DH) and 1.7 for 1000 DH. 66% (236/360) of MRSA carriers and 58% of ESBL-EB carriers were identified only by screening samples. Carriage origin was identified for year 2002: Cases were imported for 40% (26/65) of MRSA carriers and 43% (18/42) of ESBL-EB carriers. The median acquisition delays were of 31 days [3-154] for MRSA and 19 days [3-317] for ESBL-EB. This allowed to set up contact precautions for more than 2 fold patients that would have allowed diagnosis samples alone.</abstract><cop>France</cop><pmid>15596310</pmid><doi>10.1016/j.patbio.2004.09.002</doi><tpages>5</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0369-8114
ispartof	Pathologie biologie (Paris), 2004-12, Vol.52 (10), p.602-606
issn	0369-8114
language	fre
recordid	cdi_proquest_miscellaneous_67171452
source	MEDLINE; Access via ScienceDirect (Elsevier)
subjects	Drug Resistance, Bacterial Enterobacteriaceae - drug effects Humans Methicillin Resistance Rehabilitation Staphylococcus aureus - drug effects
title	Routine screening of antibiotic-resistant bacteria in acute rehabilitation units
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T10%3A47%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Routine%20screening%20of%20antibiotic-resistant%20bacteria%20in%20acute%20rehabilitation%20units&rft.jtitle=Pathologie%20biologie%20(Paris)&rft.au=Lawrence,%20C&rft.date=2004-12&rft.volume=52&rft.issue=10&rft.spage=602&rft.epage=606&rft.pages=602-606&rft.issn=0369-8114&rft_id=info:doi/10.1016/j.patbio.2004.09.002&rft_dat=%3Cproquest_pubme%3E67171452%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67171452&rft_id=info:pmid/15596310&rfr_iscdi=true